Prospective, randomized, multi-institutional clinical trial of a silver alginate dressing to reduce lower extremity vascular surgery wound complications

被引:45
作者
Ozaki, C. Keith [1 ]
Hamdan, Allen D. [2 ]
Barshes, Neal R. [3 ]
Wyers, Mark [2 ]
Hevelone, Nathanael D. [1 ]
Belkin, Michael [1 ]
Nguyen, Louis L. [1 ]
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Vasc & Endovasc Surg, Boston, MA 02115 USA
[2] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Vasc & Endovasc Surg, Boston, MA 02215 USA
[3] Baylor Coll Med, Michael E DeBakey Dept Surg, Div Vasc Surg & Endovasc Therapy, Houston, TX 77030 USA
关键词
SURGICAL SITE INFECTIONS; CRITICAL LIMB ISCHEMIA; BYPASS; REVASCULARIZATION; MULTICENTER; PREVENTION;
D O I
10.1016/j.jvs.2014.07.034
中图分类号
R61 [外科手术学];
学科分类号
100210 [外科学];
摘要
Objective: Wound complications negatively affect outcomes of lower extremity arterial reconstruction. By way of an investigator initiated clinical trial, we tested the hypothesis that a silver-eluting alginate topical surgical dressing would lower wound complication rates in patients undergoing open arterial procedures in the lower extremity. Methods: The study block-randomized 500 patients at three institutions to standard gauze or silver alginate dressings placed over incisions after leg arterial surgery. This original operating room dressing remained until gross soiling, clinical need to remove, or postoperative day 3, whichever was first. Subsequent care was at the provider's discretion. The primary end point was 30-day wound complication incidence generally based on National Surgical Quality Improvement Program guidelines. Demographic, clinical, quality of life, and economic end points were also collected. Wound closure was at the surgeon's discretion. Results: Participants (72% male) were 84% white, 45% were diabetic, 41% had critical limb ischemia, and 32% had claudication (with aneurysm, bypass revision, other). The overall 30-day wound complication incidence was 30%, with superficial surgical site infection as the most common. In intent-to-treat analysis, silver alginate had no effect on wound complications. Multivariable analysis showed that Coumadin (Bristol-Myers Squibb, Princeton, NJ; odds ratio [OR], 1.72; 95% confidence interval [CI], 1.03-2.87; P = .03), higher body mass index (OR, 1.05; 95% CI, 1.01-1.09; P = .01), and the use of no conduit/material (OR, 0.12; 95% CI, 0.82-3.59; P < .001) were independently associated with wound complications. Conclusions: The incidence of wound complications remains high in contemporary open lower extremity arterial surgery. Under the study conditions, a silver-eluting alginate dressing showed no effect on the incidence of wound complications.
引用
收藏
页码:419 / 426
页数:8
相关论文
共 18 条
[1]
Updated Recommendations for Control of Surgical Site Infections [J].
Alexander, J. Wesley ;
Solomkin, Joseph S. ;
Edwards, Michael J. .
ANNALS OF SURGERY, 2011, 253 (06) :1082-1093
[2]
Surgical site infections following colorectal cancer surgery: a randomized prospective trial comparing common and advanced antimicrobial dressing containing ionic silver [J].
Biffi, Roberto ;
Fattori, Luca ;
Bertani, Emilio ;
Radice, Davide ;
Rotmensz, Nicole ;
Misitano, Pasquale ;
Cenciarelli, Sabine ;
Chiappa, Antonio ;
Tadini, Liliana ;
Mancini, Marina ;
Pesenti, Giovanni ;
Andreoni, Bruno ;
Nespoli, Angelo .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2012, 10
[3]
Impact of an absorbent silver-eluting dressing system on lower extremity revascularization wound complications [J].
Childress, Beverly B. ;
Berceli, Scott A. ;
Nelson, Peter R. ;
Lee, W. Anthony ;
Ozaki, C. Keith .
ANNALS OF VASCULAR SURGERY, 2007, 21 (05) :598-602
[4]
Results of PREVENT III: A multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery [J].
Conte, MS ;
Bandyk, DF ;
Clowes, AW ;
Moneta, GL ;
Seely, L ;
Lorenz, TJ ;
Namini, H ;
Hamdan, AD ;
Roddy, SP ;
Belkin, M ;
Berceli, SA ;
DeMasi, RJ ;
Samson, RH ;
Berman, SS .
JOURNAL OF VASCULAR SURGERY, 2006, 43 (04) :742-750
[5]
Galli Melissa M, 2013, Foot Ankle Spec, V6, P422, DOI 10.1177/1938640013507108
[6]
Body Mass Index: Surgical Site Infections and Mortality after Lower Extremity Bypass from the National Surgical Quality Improvement Program 2005-2007 [J].
Giles, Kristina A. ;
Hamdan, Allen D. ;
Pomposelli, Frank B. ;
Wyers, Mark C. ;
Siracuse, Jeffrey J. ;
Schermerhorn, Marc L. .
ANNALS OF VASCULAR SURGERY, 2010, 24 (01) :48-56
[7]
Predictors of surgical site infection after open lower extremity revascularization [J].
Greenblatt, David Yu ;
Rajamanickam, Victoria ;
Mell, Matthew W. .
JOURNAL OF VASCULAR SURGERY, 2011, 54 (02) :433-439
[8]
Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support [J].
Harris, Paul A. ;
Taylor, Robert ;
Thielke, Robert ;
Payne, Jonathon ;
Gonzalez, Nathaniel ;
Conde, Jose G. .
JOURNAL OF BIOMEDICAL INFORMATICS, 2009, 42 (02) :377-381
[9]
Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526
[10]
Endoscopic Vein Harvesting in Lower Extremity Arterial Bypass: A Systematic Review [J].
Jauhari, Y. A. ;
Hughes, C. O. ;
Black, S. A. ;
Jones, K. G. ;
Hinchliffe, R. J. ;
Thompson, M. M. ;
Holt, P. J. ;
Karthikesalingam, A. .
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2014, 47 (06) :621-639